Drug Shortage Report for SANDOZ AMBRISENTAN TABLETS

Last updated on 2024-04-02 History
Report ID 217887
Drug Identification Number 02526875
Brand name SANDOZ AMBRISENTAN TABLETS
Common or Proper name AMBRISENTAN TABLETS
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) AMBRISENTAN
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30FCT
ATC code C02KX
ATC description OTHER ANTIHYPERTENSIVES
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2024-01-30
Estimated end date 2024-04-12
Actual end date
Shortage status Actual shortage
Updated date 2024-04-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2024-01-30 English Compare
v2 2024-01-30 French Compare
v3 2024-01-31 English Compare
v4 2024-02-12 English Compare
v5 2024-02-12 French Compare
v6 2024-02-19 English Compare
v7 2024-02-19 French Compare
v8 2024-02-19 English Compare
v9 2024-02-19 French Compare
v10 2024-03-05 English Compare
v11 2024-03-05 French Compare
v12 2024-03-18 English Compare
v13 2024-03-18 French Compare
v14 2024-04-02 English Compare
v15 2024-04-02 French Compare

Showing 1 to 15 of 15